Scolaris Content Display Scolaris Content Display

Cochrane Central Register of Controlled Trials

Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study

Raffi F, Rachlis A, Stellbrink HJ, Hardy WD, Torti C, Orkin C, Bloch M, Podzamczer D, Pokrovsky V, Pulido F, Almond S, Margolis D, Brennan C, Min S, SPRING‐2 Study Group
Lancet (london, england), 2013, 381(9868), 735‐743 | added to CENTRAL: 31 July 2013 | 2013 Issue 7
https://doi.org/10.1016/S0140-6736(12)61853-4
Sourced from:
PubMed
Links: PubMed ClinicalTrials.gov
Unlock the abstract